Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.81%
1,084.00
-8.80
-0.81%
—1,092.801,093.681,094.851,083.04——
SIXC
Communications
SIXC
Communications
SIXC
-0.39%
602.38
-2.36
-0.39%
—604.74604.74605.10601.34——
SIXE
Energy
SIXE
Energy
SIXE
+2.00%
1,239.15
+24.35
+2.00%
—1,214.801,220.811,243.821,220.81——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.73%
1,712.03
-12.54
-0.73%
—1,724.571,727.021,732.301,707.43——
SIXM
Financials
SIXM
Financials
SIXM
-0.04%
639.20
-0.23
-0.04%
—639.43641.58644.53637.50——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
837.63
-1.52
-0.18%
—839.15836.90840.48832.89——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.37%
214.82
-0.80
-0.37%
—215.62215.62216.21213.83——
SIXT
Technology
SIXT
Technology
SIXT
+0.13%
3,183.81
+4.29
+0.13%
—3,179.523,191.503,205.093,178.00——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.63%
930.97
-5.94
-0.63%
—936.91935.42937.17929.10——
SIXV
Health care
SIXV
Health care
SIXV
-0.87%
1,440.11
-12.66
-0.87%
—1,452.771,445.931,447.431,434.91——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.28%
2,358.66
-6.52
-0.28%
—2,365.182,353.642,368.102,347.80——
600664:SHA
Harbin Pharmaceutical Group Co Ltd
CNÂ¥3.68
-0.27%
(-0.0100) 1D
Apr 29, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600664...
Open
CNÂ¥3.65
High
CNÂ¥3.69
Low
CNÂ¥3.58
Mkt. cap
9.29B
Avg. vol.
153.45M
Volume
96.11M
P/E ratio
29.92
52-wk high
CNÂ¥4.88
52-wk low
CNÂ¥3.20
EPS
CNÂ¥0.12
Shares outstanding
2.54B
No. of employees
10K
News stories
From sources across the web
Profile
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate. The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
About Harbin Pharmaceutical Group Co Ltd
CEO-
Employees10K
Founded1988
Headquarters-
SectorPharmaceutical industry
Websitehayao.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.95B
3.90B
3.94B
4.18B
Cost of goods sold
2.89B
2.95B
2.92B
3.17B
Cost of revenue
2.89B
2.95B
2.92B
3.17B
Research and development expenses
28.95M
33.63M
51.31M
27.02M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
875.58M
753.48M
821.63M
721.16M
Operating expense
962.08M
838.57M
772.76M
770.11M
Total operating expenses
3.85B
3.78B
3.70B
3.94B
Operating income
102.71M
112.30M
247.02M
236.41M
Other non operating income
-14.46M
468.22K
-112.38M
-29.98M
EBT including unusual items
90.25M
119.12M
91.70M
206.43M
EBT excluding unusual items
84.39M
109.94M
145.22M
206.42M
Income tax expense
45.09M
41.30M
34.62M
45.36M
Effective tax rate
49.97%
34.67%
37.75%
21.97%
Other operating expenses
29.37M
24.67M
-36.43M
21.94M
Net income
46.78M
68.89M
33.00M
161.13M
Net profit margin
1.18%
1.77%
0.84%
3.86%
Earnings per share
-
-
-
-
Interest and investment income
10.53M
4.05M
31.79M
-
Interest expense
-10.21M
-11.05M
-21.21M
-
Net interest expenses
323.11K
-7.00M
10.58M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
156.21M
166.37M
304.32M
293.71M
Gain or loss from assets sale
-3.99M
3.99M
-3.83M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer